Business Briefing: Court Bars Removal of Cheaper Alzheimer’s Drug

A federal appeals court in New York ruled on Friday that Actavis cannot withdraw its top-selling Alzheimer’s disease drug from the market in favor of a more expensive extended-release version.









from NYT > Health http://ift.tt/1FJk15G
via health&fitness